13-48001221-G-C

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting

The NM_003850.3(SUCLA2):ā€‹c.49C>Gā€‹(p.Arg17Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000271 in 1,608,810 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.00023 ( 0 hom., cov: 34)
Exomes š‘“: 0.00028 ( 1 hom. )

Consequence

SUCLA2
NM_003850.3 missense

Scores

1
3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:2

Conservation

PhyloP100: 0.263
Variant links:
Genes affected
SUCLA2 (HGNC:11448): (succinate-CoA ligase ADP-forming subunit beta) Succinyl-CoA synthetase (SCS) is a mitochondrial matrix enzyme that acts as a heterodimer, being composed of an invariant alpha subunit and a substrate-specific beta subunit. The protein encoded by this gene is an ATP-specific SCS beta subunit that dimerizes with the SCS alpha subunit to form SCS-A, an essential component of the tricarboxylic acid cycle. SCS-A hydrolyzes ATP to convert succinate to succinyl-CoA. Defects in this gene are a cause of myopathic mitochondrial DNA depletion syndrome. A pseudogene of this gene has been found on chromosome 6. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06358954).
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.000275 (401/1456502) while in subpopulation MID AF= 0.00434 (25/5756). AF 95% confidence interval is 0.00302. There are 1 homozygotes in gnomad4_exome. There are 198 alleles in male gnomad4_exome subpopulation. Median coverage is 34. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SUCLA2NM_003850.3 linkuse as main transcriptc.49C>G p.Arg17Gly missense_variant 1/11 ENST00000646932.1 NP_003841.1 Q9P2R7-1E5KS60Q9Y4T0

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SUCLA2ENST00000646932.1 linkuse as main transcriptc.49C>G p.Arg17Gly missense_variant 1/11 NM_003850.3 ENSP00000494360.1 Q9P2R7-1

Frequencies

GnomAD3 genomes
AF:
0.000230
AC:
35
AN:
152190
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000279
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000321
AC:
76
AN:
236526
Hom.:
0
AF XY:
0.000318
AC XY:
41
AN XY:
129122
show subpopulations
Gnomad AFR exome
AF:
0.0000698
Gnomad AMR exome
AF:
0.000150
Gnomad ASJ exome
AF:
0.00308
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000348
Gnomad OTH exome
AF:
0.000520
GnomAD4 exome
AF:
0.000275
AC:
401
AN:
1456502
Hom.:
1
Cov.:
34
AF XY:
0.000273
AC XY:
198
AN XY:
724282
show subpopulations
Gnomad4 AFR exome
AF:
0.000210
Gnomad4 AMR exome
AF:
0.000181
Gnomad4 ASJ exome
AF:
0.00312
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000234
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000230
Gnomad4 OTH exome
AF:
0.000383
GnomAD4 genome
AF:
0.000230
AC:
35
AN:
152308
Hom.:
0
Cov.:
34
AF XY:
0.000201
AC XY:
15
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000188
Gnomad4 NFE
AF:
0.000279
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000537
Hom.:
0
Bravo
AF:
0.000295
ESP6500AA
AF:
0.000228
AC:
1
ESP6500EA
AF:
0.000350
AC:
3
ExAC
AF:
0.000232
AC:
28

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:6Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:4
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicJul 30, 2024BS1 -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxDec 05, 2024In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 20843780) -
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jun 20, 2016- -
Uncertain significance, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsJul 06, 2017- -
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitterclinical testingBaylor GeneticsNov 20, 2019This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 26, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
SUCLA2-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesApr 03, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Benign
-0.11
CADD
Benign
15
DANN
Benign
0.68
DEOGEN2
Benign
0.18
T;T;.;T;.;.;T
Eigen
Benign
-0.36
Eigen_PC
Benign
-0.42
FATHMM_MKL
Benign
0.46
N
LIST_S2
Benign
0.60
.;T;T;T;T;T;T
M_CAP
Pathogenic
0.96
D
MetaRNN
Benign
0.064
T;T;T;T;T;T;T
MetaSVM
Benign
-0.45
T
MutationAssessor
Benign
0.81
L;L;.;.;.;.;.
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
0.080
.;N;.;N;.;.;.
REVEL
Uncertain
0.39
Sift
Benign
0.11
.;T;.;T;.;.;.
Sift4G
Uncertain
0.029
.;D;.;.;.;.;D
Polyphen
0.95
P;P;.;.;.;.;.
Vest4
0.66, 0.69
MVP
0.68
MPC
0.63
ClinPred
0.053
T
GERP RS
2.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.16
gMVP
0.51

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200124902; hg19: chr13-48575357; COSMIC: COSV66223216; COSMIC: COSV66223216; API